Prozac (Fluoxetine) News and Research

RSS

Antidepressants should not be avoided in treatment of pregnant women with severe depression

Antidepressants to treat from moderate to severe depression in pregnant women not only are relatively safe but necessary in many cases for the well-being of the mother and the baby

7 Jul 2004

Drug combination reduces cocaine use

Researchers at the Yerkes National Primate Research Center are the first to demonstrate that a combination of drug therapies targeting the region of the brain that controls drug abuse and addiction significantly reduces cocaine use in nonhuman primates.

15 Jun 2004

Canadians advised of stronger warnings for selective serotonin re-uptake inhibitors and other newer anti-depressants

Health Canada is advising Canadians that Selective Serotonin Re-uptake Inhibitors (SSRIs) and other newer anti-depressants, now carry stronger warnings. These new warnings indicate that patients of all ages taking these drugs may experience behavioural and/or emotional changes that may put them at increased risk of self-harm or harm to others.

11 Jun 2004

Contradictory views on the use of Prozac to treat children with depression

A new US Government study suggests that anti-depressants such as Eli Lilly and Co's Prozac are the best way to treat children with depression.

3 Jun 2004

Adrenaline packs a powerful punch in the use of antidepressants

Researchers from the University of Pennsylvania School of Medicine found that norepinephrine (adrenaline) plays an important role in animals in determining behavioral effects in some of the most commonly prescribed antidepressants, regardless of which biochemical pathway the drug uses to alleviate symptoms of depression.

3 Jun 2004

Combination drug therapies targeting brain region that controls addiction significantly reduces cocaine use in primates

Researchers at the Yerkes National Primate Research Center of Emory University are the first to demonstrate a combination of drug therapies targeting the region of the brain that controls drug abuse and addiction significantly reduces cocaine use in nonhuman primates.

24 May 2004

A new synthetic chemical may provide framework for future drugs to treat brain-based ailments

A new synthetic chemical may provide the framework for future drugs that can treat a variety of brain-based ailments, ranging from overeating and drug dependency to neuropathic pain.

19 May 2004

Public Health Advisory for medical professionals with patients on anti-depression medication

On Monday, March 22, 2004 the Food and Drug Administration issued a Public Health Advisory for medical professionals to monitor for signs of suicidal ideation in individuals who have recently started taking anti-depression medication or have had a recent change in dosage, especially for children who are taking these medications. Antidepressant medications involved in this warning include: Prozac (Fluoxetine), Zoloft, Paxil, Luvox, Celexa, Lexapro, Wellbutrin, Effexor,, Serzone, and Remeron.

25 Apr 2004

SSRI antidepressants may be unsuitable for children

A UK study in this week's issue of THE LANCET suggests that reliance on published studies alone to guide the treatment of childhood depression could be inappropriate. A systematic review including published and unpublished data shows that only one drug, fluoxetine (Prozac), was not associated with negative outcomes for children with depression.

22 Apr 2004

Trials of antidepressants for children consistently exaggerated their benefits while playing down their possible harm

Antidepressants should not be used to treat children and teenagers, a controversial new Australian study has warned, saying clinical trials have exaggerated the benefits of the drugs and played down their side effects.

10 Apr 2004

The Food and Drug Administration issues warning on antidepressants

The Food and Drug Administration (FDA) is issuing a warning about the possibility of worsening depression or suicidal thought in people, particularly children, who take any of 10 popular antidepressants, especially at the beginning of treatment or when the dosage is changed.

6 Apr 2004